Lantern Pharma Inc.

NASDAQ:LTRN

3.31 (USD) • At close November 1, 2024
Bedrijfsnaam Lantern Pharma Inc.
Symbool LTRN
Munteenheid USD
Prijs 3.31
Beurswaarde 35,631,157
Dividendpercentage 0%
52-weken bereik 2.72 - 11.99
Industrie Biotechnology
Sector Healthcare
CEO Mr. Panna Sharma PH.D.
Website https://www.lanternpharma.com

An error occurred while fetching data.

Over Lantern Pharma Inc.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a

Vergelijkbare Aandelen

BioVie Inc. logo

BioVie Inc.

BIVI

2.77 USD

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

4.71 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

6.01 USD

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.06 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.8 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.83 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)